Market Cap 13.59B
Revenue (ttm) 2.89B
Net Income (ttm) 1.12B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 10.80
Profit Margin 38.89%
Debt to Equity Ratio 0.00
Volume 145,900
Avg Vol 83,196
Day's Range N/A - N/A
Shares Out 1.70B
Stochastic %K 64%
Beta 0.20
Analysts Sell
Price Target $10.30

Company Profile

Shionogi & Co., Ltd. researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices. It offers and develops drugs in the areas of infectious diseases, COVID-19, tumors, sclerosis, pomp, fragile X syndrome, and other diseases. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 81 6 6202 2161
Fax: 81 6 6229 9596
Address:
1-8, Doshomachi 3-chome, Chuo-ku, Osaka, Japan
Latest News on SGIOY
No data available.